Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedUpgrade from Revision: v3.0.2 to v3.2.0, add government operating-status notice with new contact numbers; core content and access/operating status information updated.SummaryDifference2%
- Check27 days agoChange DetectedRemoved several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a narrowing of the page content.SummaryDifference0.3%
- Check34 days agoChange Detected- Updated recruitment statuses and expanded location list (adds 2025-09-16 locations and a total of 260 sites; includes new U.S. and Canada sites). - Removed prior data (257 locations, earlier dates, older status terms) and replaced with new timestamps and statuses.SummaryDifference2%
- Check41 days agoChange DetectedVersion bump from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no other content changes detected.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check55 days agoChange DetectedThe web page has been updated to include a new facility name and a comprehensive list of locations across various countries, while also removing outdated location entries. The total number of study locations has been adjusted from 258 to 257.SummaryDifference19%
Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.